Switch theme
Sign up to access all valuation multiples
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and advanced precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is primarily generated from its hospital business and its medical equipment, software, and related services segment.
2008
733
LTM Revenue n/a
LTM EBITDA n/a
$1.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Concord Medical has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Concord Medical achieved revenue of $69.3M and an EBITDA of -$22.2M.
Concord Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Concord Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $60.7M | $69.3M | XXX | XXX | XXX |
| Gross Profit | -$6.1M | -$18.3M | XXX | XXX | XXX |
| Gross Margin | -10% | -26% | XXX | XXX | XXX |
| EBITDA | -$28.9M | -$22.2M | XXX | XXX | XXX |
| EBITDA Margin | -48% | -32% | XXX | XXX | XXX |
| Net Profit | -$105M | -$69.6M | XXX | XXX | XXX |
| Net Margin | -173% | -101% | XXX | XXX | XXX |
| Net Debt | $271M | $294M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Concord Medical's stock price is HKD 7 (or $1).
Concord Medical has current market cap of HKD 4.9B (or $632M), and EV of HKD 8.0B (or $1.0B).
See Concord Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.0B | $632M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Concord Medical has market cap of $632M and EV of $1.0B.
Concord Medical's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Concord Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Concord Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.0B | XXX | XXX | XXX |
| EV/Revenue | 14.8x | XXX | XXX | XXX |
| EV/EBITDA | -46.2x | XXX | XXX | XXX |
| P/E | -13.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 440.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpConcord Medical's NTM/LTM revenue growth is n/a
Concord Medical's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Concord Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Concord Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Concord Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -32% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -23% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 54% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Concord Medical acquired XXX companies to date.
Last acquisition by Concord Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Concord Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Concord Medical founded? | Concord Medical was founded in 2008. |
| Where is Concord Medical headquartered? | Concord Medical is headquartered in Hong Kong. |
| How many employees does Concord Medical have? | As of today, Concord Medical has 733 employees. |
| Is Concord Medical publicy listed? | Yes, Concord Medical is a public company listed on HKG. |
| What is the stock symbol of Concord Medical? | Concord Medical trades under 02453 ticker. |
| When did Concord Medical go public? | Concord Medical went public in 2024. |
| Who are competitors of Concord Medical? | Similar companies to Concord Medical include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Concord Medical? | Concord Medical's current market cap is $632M |
| What is the current revenue growth of Concord Medical? | Concord Medical revenue growth between 2023 and 2024 was 14%. |
| Is Concord Medical profitable? | Yes, Concord Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
